Chihiro Yamamoto

6PUBLICATIONS
20CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityGene and molecular therapyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 07, 2026
Cost-effectiveness of blinatumomab as post-remission therapy in adults with measurable residual disease-negative, Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.

Chihiro Yamamoto, Teruaki Yamaguchi, Seina Honda

|Mar 24, 2025
Impact of daratumumab on the development of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.

Daisuke Minakata, Shin-Ichiro Fujiwara, Seina Honda

|Jun 26, 2023
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.

Kento Umino, Kaoru Morita, Takashi Ikeda

|Jan 20, 2023
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies.

Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama

|May 17, 2022
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.

Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama

|Nov 03, 2020
Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease.

Kaoru Morita, Shin-Ichiro Fujiwara, Takashi Ikeda

Pageof 1

Frequent Collaborators

5 joint publications

Kazuya Sato

3 joint publications

Kaoru Morita

3 joint publications

Yoshinobu Kanda

3 joint publications

Shin-Ichiro Fujiwara